A Fight to Save Kids and Change Science

Monday, November 25, 2013

Wall Street Journal reporter Amy Dockser Marcus discusses her investigative health piece, โ€œTrials.โ€ For six years, The Wall Street Journal followed a group of parents and scientists seeking a treatment for a rare and fatal genetic disease (Niemann-Pick Type C) that strikes primarily children. Their collaboration accelerated development of a promising drug and, along the way, pushed the boundaries of medical science itself.


Amy Dockser Marcus

Comments [3]

Truth & Beauty from Brooklyn

@ thatgirl from manhattan: That may be so, but Ms. Marcus didn't even mention them. I googled this condition when they started their discussion and it said it is because of aggregate cholesterol in various organs and statins are the first thing that came to mind, but didn't make it into the discussion.

@ Independent_Noach: What the H**L are you talking about?!? How is that even remotely related to this discussion?

Nov. 25 2013 02:17 PM
thatgirl from manhattan

Statins aren't right for everyone--in fact, they're right for fewer people than pharma would have you believe.

Nov. 25 2013 01:12 PM
Truth & Beauty from Brooklyn

If it's a problem with cholesterol, why don't they treat them with statins?

Nov. 25 2013 12:25 PM

Leave a Comment

Email addresses are required but never displayed.

Get the WNYC Morning Brief in your inbox.
We'll send you our top 5 stories every day, plus breaking news and weather.